34
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Call for Papers: Digital Platforms and Artificial Intelligence in Dementia

      Submit here by August 31, 2025

      About Dementia and Geriatric Cognitive Disorders: 1.9 Impact Factor I 5.3 CiteScore I 0.781 Scimago Journal & Country Rank (SJR)

      Call for Papers: Skin Health in Aging Populations

      Submit here by December 31, 2025

      About Skin Pharmacology and Physiology: 3.2 Impact Factor I 6.6 CiteScore I 0.833 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Dermatology Life Quality Index in Patients with Atopic Dermatitis: Are “Not Relevant” Responses Relevant?

      brief-report

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: According to the DLQI user manual, the patients’ answers “not relevant” (NR) and “not at all” (affected in this aspect of life by the skin problem) are treated equally and interpreted as no impairment in health-related quality of life (HRQoL). The aim of this study was to gain more insights about “NR” responders with atopic dermatitis (AD). Methods: A total of 3,353 patients with AD, recruited from dermatological offices and a patient organisation, were surveyed in three cross-sectional studies. Disease severity (SCORAD) and subjective health status (EQ VAS) were compared for each DLQI item between patients who answered “NR” and all others according to their response category. Different DLQI scoring versions were analysed. Results: Those who stated “NR” in terms of HRQoL limitations in the DLQI domains sports, work/study, and sexual relationships were comparable in AD severity and health status to those who felt that their HRQoL was “a little affected.” Some alternative DLQI scoring versions correlated slightly higher with the SCORAD and EQ VAS than the original DLQI. Conclusion: Patients with AD who rate certain life domains as “NR” in the DLQI are most similar in their disease burden to patients who feel a little affected in these areas of life. This suggests that some HRQoL limitations are underestimated by the traditional DLQI scoring. However, different scoring solutions did not lead to substantially higher correlations with other disease burden criteria compared to the original. Therefore, the gain in validity by alternative versions is small.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

          A simple practical questionnaire technique for routine clinical use, the Dermatology Life Quality Index (DLQI) is described. One hundred and twenty patients with different skin diseases were asked about the impact of their disease and its treatment on their lives; a questionnaire, the DLQI, was developed based on their answers. The DLQI was then completed by 200 consecutive new patients attending a dermatology clinic. This study confirmed that atopic eczema, psoriasis and generalized pruritus have a greater impact on quality of life than acne, basal cell carcinomas and viral warts. The DLQI was also completed by 100 healthy volunteers; their mean score was very low (1.6%, s.d. 3.5) compared with the mean score for the dermatology patients (24.2%, s.d. 20.9). The reliability of the DLQI was examined in 53 patients using a 1 week test-retest method and reliability was found to be high (gamma s = 0.99).
            • Record: found
            • Abstract: not found
            • Article: not found

            EuroQol: the current state of play

              • Record: found
              • Abstract: found
              • Article: not found

              Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis.

              Assessment methods for atopic dermatitis (AD) are not standardized, and therapeutic studies are difficult to interpret. To obtain a consensus on assessment methods in AD and to use a statistical method to develop a composite severity index. Consensus definitions were given for items used in the scoring system (extent, intensity, subjective) and illustrated for intensity items. Slides were reviewed to address within- and between-observer variability by a group of 10 trained clinicians, and data were statistically evaluated with a two-way analysis of variance. Two variants of an assessment system were compared in 88 patients at 5 different institutions. Data were analyzed using principal-component analysis. For 5 intensity items studied (erythema, edema/papulation, oozing/crusts, excoriations, lichenification), within- and between-observer variability was good overall, except for edema/papulation which was difficult to assess with slides. In the series of 88 patients, principal-component analysis allowed to extract two unrelated components: the first one accounting for 33% of total variance was interpreted as a 'severity' component; the second one, accounting for 18% of variance, was interpreted as a 'profile' component distinguishing patients with mostly erythema and subjective symptoms and those with mostly lichenification and dryness and lower subjective symptoms. Of the two evaluation systems used, the one using the rule of nine to assess extent was found more workable than the one using a distribution x intensity product. A scoring index (SCORAD) combining extent, severity and subjective symptoms was mathematically derived from the first system and showed a normal distribution of the population studied. The final choice for the evaluation system was mostly made based on simplicity and easy routine use in outpatient clinics. Based on mathematical appreciation of weights of the items used in the assessment of AD, extent and subjective symptoms account for around 20% each of the total score, intensity items representing 60%. The so-designed composite index SCORAD needs to be further tested in clinical trials.

                Author and article information

                Journal
                DRM
                Dermatology
                10.1159/issn.1018-8665
                Dermatology
                Dermatology
                S. Karger AG
                1018-8665
                1421-9832
                2024
                August 2024
                27 April 2024
                : 240
                : 4
                : 653-658
                Affiliations
                [ ]Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
                Author notes
                *Anna Langenbruch, a.langenbruch@uke.de
                Article
                538803 Dermatology 2024;240:653–658
                10.1159/000538803
                38679001
                97ee7b34-c396-4ab2-bb61-b6c2f3ebfe44
                © 2024 S. Karger AG, Basel
                History
                : 21 December 2022
                : 08 April 2024
                Page count
                Figures: 2, Tables: 2, Pages: 6
                Funding
                The institute received financial support for the current analyses from Almirall. The data on which the analyses are based come from various studies that were financially supported by the following companies: Astellas (AtopicHealth1), Sanofi (AtopicHealth2), German Atopic Dermatitis Patient Association (Deutscher Neurodermitis Bund, AtopicReal). The companies were not involved in study design, data collection, data analysis, interpretation of the results, and writing of the article.
                Categories
                Brief Report

                Medicine
                Atopic dermatitis,Disease burden,Dermatology Life Quality Index,Patient-reported outcomes,Quality of life

                Comments

                Comment on this article

                Related Documents Log